Enovis (ENOV) Other Operating Expenses (2022)
Enovis (ENOV) reported Other Operating Expenses of $4.6 million for Q4 2022, up 571.79% on a QoQ basis from -$975000.0 in Q3 2022.
Enovis (ENOV) has 1 years of Other Operating Expenses data on file, last reported at $4.6 million in Q4 2022.
- Quarterly Other Operating Expenses changed N/A year-over-year to $4.6 million in Q4 2022, while the trailing twelve-month figure through Sep 2023 was $4.6 million (down 85.65% YoY) and the FY2022 annual result came in at $36.7 million, changed N/A from the prior year.
- Other Operating Expenses climbed to $4.6 million in Q4 2022 per ENOV's latest filing, from -$975000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $33.0 million in Q3 2022 and bottomed at -$975000.0 in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Enovis | 1.25 Bn | 1.22 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 4.60 Mn |
| Sep 30, 2022 | -975,000.00 |
| Jul 1, 2022 | 33.03 Mn |